Viewing Study NCT03600805


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2025-12-26 @ 1:56 AM
Study NCT ID: NCT03600805
Status: TERMINATED
Last Update Posted: 2022-03-28
First Post: 2018-07-17
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA
Sponsor: Sanofi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-11-20
Start Date Type: ACTUAL
Primary Completion Date: 2020-11-24
Primary Completion Date Type: ACTUAL
Completion Date: 2020-11-24
Completion Date Type: ACTUAL
First Submit Date: 2018-07-17
First Submit QC Date: None
Study First Post Date: 2018-07-26
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-11-18
Results First Submit QC Date: None
Results First Post Date: 2022-01-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-03-15
Last Update Post Date: 2022-03-28
Last Update Post Date Type: ACTUAL